Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ron Laufer currently holds 1,409,213 shares of CATABASIS PHARMACEUTICALS INC (CATB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ron Laufer has been a net buyer of CATB stock. They have purchased $2.7M and sold $0 worth of shares.
Ron Laufer's most recent insider trade was on Jun 30, 2015, when they sold 330,098 shares at $0.00 per share.
Ron Laufer serves as Executive at CATABASIS PHARMACEUTICALS INC (CATB). They have executed 3 insider transactions totaling $2.7M over their tenure at the company.
Ron Laufer holds the position of Executive at CATABASIS PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Ron Laufer has shown a buying trading pattern, with $2.7M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Ron Laufer was on Jun 30, 2015, when they purchased $2.7M worth of CATB shares. This transaction involved 223,439 shares at $12.00 per share.
Ron Laufer currently owns 1,409,213 shares of CATABASIS PHARMACEUTICALS INC (CATB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ron Laufer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ron Laufer has 3 Form 4 filings on record as an insider at CATABASIS PHARMACEUTICALS INC.
Set alerts for Ron Laufer and 40,000+ other insiders.